How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,480 results for

Postpartum Office Visit

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1261. Domiciliary midwifery support in high-risk pregnancy incorporating telephonic fetal heart rate monitoring: a health technology randomized assessment

and domiciliary foetal monitoring, where the results of a cardiotocogram (CTG), recorded in the home, were transmitted to the hospital by telephone using modems. The frequency of surveillance was not specified in the study protocol and the patients were allowed to make hospital or office visits. Type of intervention Screening and primary prevention. Economic study type Cost-effectiveness analysis. Study population The study population comprised pregnant women displaying maternal or foetal risk factors (...) , Thompson A, Arnall C, Coles E Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The use of domiciliary care for pregnant women at risk of adverse outcomes. Enhanced domiciliary care comprised home visits from community midwives

1999 NHS Economic Evaluation Database.

1262. University hospital-based prenatal care decreases the rate of preterm delivery and costs, when compared to managed care

and benefits would have shown that the HS intervention dominated MCO as it led to lower costs and higher effectiveness (as estimated using the primary outcome measure). Authors' conclusions The authors concluded that an MCO approach led to greater total expenditures and less effective clinical outcomes in the population of indigent women with a history of preterm delivery. The authors commented that such results were likely to have been affected by shorter prenatal office visits resulting in decreased (...) gestational age for preterm deliveries, number of prenatal visits, number of antepartum admissions, cervical dilatation on presentation to labour and delivery ward, total Caesarean section rate, and several neonatal outcome variables, such as neonatal intensive care unit (NICU) admissions, NICU length of stay, and perinatal mortality rate. Study groups were shown to be comparable at baseline in terms of maternal age, proportion of non-white patients, and parity characteristics. Effectiveness results

2001 NHS Economic Evaluation Database.

1263. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women: implications for a national Chlamydia control strategy

of treating sequelae of untreated infection in women, costs of neonatal disease, and costs of disease in male sex partners. The quantity/cost boundary adopted was that of the health service. The estimation of quantities and costs was based on actual data. The costs for clinic visits and for the treatment of uncomplicated chlamydial infection and outpatient PID were obtained from the Region X Office of Family Planning. Costs for inpatient treatment and for sequelae of untreated infection were updated using (...) versus prevalent and symptomatic versus asymptomatic infections in the FP and STD settings. Several less common but costly outcomes, in which chlamydia trachomatis may play a causative role, such as low birth weight and post-partum endometritis were not considered. The generalisability of the results to other settings was discussed and adequate comparisons with other relevant studies were made. Implications of the study More data are needed on the various effectiveness measures and other diagnostic

1997 NHS Economic Evaluation Database.

1264. Effectiveness reviews in health promotion

quality criteria to assess primary studies are essential, as well as regular updating. However, review methods may be adapted to suit health promotion better by: employing the quality criteria of >sound= primary studies (comparable groups studied; pre- and post-test data reported for all groups on all outcomes targeted) rather than the quality criteria of random allocation or blinded random allocation (which are rarely reported in the field of health promotion). ? Advances in search strategies (...) healthy eating interventions which were implemented in the workplace to change participants= cholesterol levels. Fifty-two reports of relevant outcome evaluations were identified and reviewed according to a standardised quality assessment procedure (the >EPI-Centre quality criteria=). Twelve studies met the quality criteria of employing a viii control/comparison group equivalent to the intervention group in socio-demographic characteristics and baseline outcome measures; and reporting of pre- and post

1999 EPPI Centre

1265. APA Guidelines on Multicultural Education, Training, Research, Practice and Organizational Change for Psychologists

for Psychologists (APA, 2002) was released, there has been significant growth in research and theory regarding multicultural contexts. The guidelines were passed by the American Psychological Association (APA) Council of Representatives at the 2002 annual conference and were posted on the APA website. The attention given to these guidelines, including their publication in the American Psychologist (2003), speaks to the profession’s recognition of the important role that diversity and multiculturalism play, both

2002 American Psychological Association

1266. Establishing Therapeutic Relationships

-Lou Martin, RN, PhD(cand.) Clinical Nurse Specialist St. Joseph’s Health Care, Hamilton Centre for Mountain Health Services Clinical Associate Professor, McMaster University Hamilton, Ontario Trish Robinson, RN, BScN Outreach Mental Health Coordinator St. Michael’s Hospital Toronto, Ontario Selinah Sogbein, RN, MHA, MEd Assistant Chief Nursing Officer/Coordinator Clinical Services North Bay Psychiatric Hospital North Bay, Ontario Heather Sutcliffe, RN, BScN Public Health Nurse Wellington Dufferin (...) Guidelines Project 111 Richmond Street West, Suite 1208 Toronto, Ontario M5H 2G4 Website: www.rnao.org Nursing Best Practice Guideline 3Barbara Cadotte Psychiatric Patient Advocate Office Ontario Ministry of Health and Long-Term Care Toronto, Ontario David Simpson Psychiatric Patient Advocate Regional Mental Health Centre Ontario Ministry of Health and Long-Term Care St. Thomas, Ontario Deborah Sherman Executive Director Mental Health Rights Coalition of Hamilton/Wentworth Hamilton, Ontario Elizabeth

2002 Registered Nurses' Association of Ontario

1267. Value of Urodynamic Evaluation

* Currently undergoing or has had recommended treatment of apical or anterior prolapse No anterior or apical prolapse > +1 on standing straining prolapse exam Pregnant or has not completed child bearing. <12 months post-partum*† Active malignancy of cervix, uterus, fallopian tube(s) or ovary > Stage I, or bladder of any Stage History of pelvic radiation therapy Previous incontinence surgery Current catheter use Neurological disease known to affect bladder storage (e.g. MS, Parkinsonism, CVA) Previous (i.e (...) is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00803959 Recruitment Status : Completed First Posted : December 8, 2008 Results First Posted : August 6, 2013 Last Update Posted : August 6, 2013 Sponsor: New England Research Institutes Collaborators: University of Alabama at Birmingham University of California, San Diego University of Maryland University

2008 Clinical Trials

1268. Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder

Canada Sanofi-Aventis Administrative Office Laval, Canada Sponsors and Collaborators Sanofi Investigators Layout table for investigator information Study Director: ICD CSD Sanofi More Information Go to Additional Information: Layout table for additonal information Responsible Party: ICD Study Director, sanofi-aventis ClinicalTrials.gov Identifier: Other Study ID Numbers: EFC5041 First Posted: November 11, 2005 Last Update Posted: March 12, 2009 Last Verified: March 2009 Keywords provided by Sanofi (...) and Safety of SR58611A in Patients With Major Depressive Disorder (ORION) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00252356 Recruitment Status : Completed First Posted : November 11, 2005 Last Update Posted : March 12, 2009 Sponsor: Sanofi Information provided by: Sanofi Study Details Study

2005 Clinical Trials

1269. Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder

and Safety of SR58611A in Patients With Major Depressive Disorder (PHOENIX) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00252330 Recruitment Status : Completed First Posted : November 11, 2005 Last Update Posted : March 12, 2009 Sponsor: Sanofi Information provided by: Sanofi Study Details Study (...) . A Safety Follow up Visit is scheduled 1 week after the acute and extension period, or early termination. Escitalopram, a selective serotonin reuptake inhibitor (SSRI), an approved treatment for MDD, is chosen as a positive control agent in this study. The dose of 10 mg is within the approved dose range with no need for dose adjustment in elderly patients. This trial is designed to formally compare the efficacy, safety, and tolerability of SR58611A to placebo. Escitalopram is used as a positive control

2005 Clinical Trials

1270. Pennsylvania Abusive Head Trauma Prevention Program

various socioeconomic groups. Determine the cost effectiveness of the hospital-based program. Establish the feasibility, additional costs, and effectiveness of a combined program of repeated exposure delivered both post-natally in the hospital and during follow up 2-, 4- and 6-month outpatient health maintenance visits with the pediatric care provider. Condition or disease Intervention/treatment Phase Injury Traumatic Brain Injury Child Abuse Behavioral: PA Abusive Head Trauma Prevention Program (...) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00727116 Recruitment Status : Completed First Posted : August 1, 2008 Last Update Posted : February 9, 2015 Sponsor: Centers for Disease Control and Prevention Collaborators: Pennsylvania Department of Health American Academy of Pediatrics Information

2008 Clinical Trials

1271. Exploring Semi-Quantitative Pregnancy Tests and Their Impact on Reproductive Health Service Provision

Criteria: Women 18 years or older, presenting for early abortion, pre-natal care, or fertility services. If pregnant, gestational age < 84 days by LMP, ultrasound or clinical assessment. Agrees to return for follow-up visit and willing to provide an address and/or telephone number for purposes of follow-up. Able to consent to study participation. Exclusion Criteria: Women less than 18 years of age. Women who are not pregnant, except if presenting for IVF services. Contacts and Locations Go (...) remove one or more studies before adding more. Exploring Semi-Quantitative Pregnancy Tests and Their Impact on Reproductive Health Service Provision The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00812890 Recruitment Status : Completed First Posted : December 22, 2008 Last Update Posted : July 22

2008 Clinical Trials

1272. T- BOOM Teens--Building Options and Opportunities for Moms

depression screening and care management program for postpartum women. We will evaluate the: 1) how often (frequency) young mothers develop symptoms of depression 4 to 6 weeks after birth, 2) how quickly (timeliness) young mother receive treatment and how effective (adequacy) are the treatments for the symptoms of postpartum depression, 3) the effects of depression care support on young mothers' symptoms and their ability to function at 3, 6 and 12 months after entering the study, 4) visits (...) Frame: Trained interviewers will complete the CDRS at baseline, 3, 6, and 12 months postpartum. ] Edinburgh Postnatal Depression Scale [ Time Frame: Baseline, 3, 6, and 12 months ] Center for Epidemiologic Studies of Depression instrument (CES-D) [ Time Frame: Baseline, 3, 6 and 12 months ] Secondary Outcome Measures : A specific measure of functioning at school or work and with peers, the Children's Global Assessment of Functioning (C-GAS) will be obtained. [ Time Frame: baseline, 3, 6, and 12

2008 Clinical Trials

1273. Maternal Fatty Acids, Child Obesity, and Asthma Immunity

by (Responsible Party): Matthew W. Gillman, MD, SM, Harvard Pilgrim Health Care Study Details Study Description Go to Brief Summary: To study pre- and post-natal influences on the development of childhood asthma-related immune responses. Condition or disease Asthma Lung Diseases Detailed Description: BACKGROUND: Since most cases of asthma occur in the first few years of life, examining its pre- and early postnatal determinants is crucial. This study focuses on determinants of the developing immune system. T (...) -Probability Sample Study Population Pregnant women were recruited in 1999-2002 following their initial prenatal visit at one of eight obstetric offices of a multi-specialty group practice in eastern MA. Criteria Women were eligible for participation in Project Viva if they: Were <22 weeks pregnant Planned to receive prenatal care at one of the selected clinics Planned to deliver at one of the two study hospitals Were able to answer questions in English Women were ineligible if they: Planned to terminate

2004 Clinical Trials

1274. Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women

( Other Grant/Funding Number: Office of AIDS Research ) First Posted: March 5, 2008 Last Update Posted: July 27, 2016 Last Verified: July 2016 Keywords provided by Jeannette Ickovics, Yale University: HIV Prevention Teen Pregnancy Translational Research Group Care Prenatal Care STD Prevention Gonorrhea Chlamydia Adolescent Health Community Health Centers CenteringPregnancy Plus HIV seronegativity Additional relevant MeSH terms: Layout table for MeSH terms HIV Infections Sexually Transmitted Diseases (...) studies before adding more. Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00628771 Recruitment Status : Completed First Posted : March 5, 2008 Last Update Posted : July 27, 2016 Sponsor: Yale University

2008 Clinical Trials

1275. A Study to Evaluate Associations Between Gingivitis and Pregnancy Outcomes

by the National Library of Medicine related topics: Groups and Cohorts Go to Group/Cohort Intervention/treatment Observation Pregnant women with gingivitis Behavioral: counseling The 8-week study includes 3 visits to the dental facility at the Center for Women's Reproductive Health at UAB. Study visits are scheduled to coincide with pre-natal visits in the same facility. Each visit will include individually tailored one-to-one discussion with a dental professional coupled with a demonstration and instructions (...) for using oral hygiene products. Home-care kits will be dispensed, to include a helpful digital video disk (DVD), a high-tech powered toothbrush, dental floss, toothpaste and alcohol-free mouth rinse and subjects will have their teeth professionally cleaned. First and final visits will include collection of gingival crevicular fluid and blood samples and subjects will complete pre and post study questionnaires. Other Names: Pre and Post-study questionnaires Instructional DVD Brushing and flossing

2008 Clinical Trials

1276. A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression

and pulse rate were measured after 2 minutes rest in a supine position. High values were: diastolic blood pressure ≥90 mm Hg and increase from baseline of ≥10 mm Hg; systolic blood pressure ≥140 mm Hg and increase from baseline of ≥10 mm Hg; pulse rate ≥100 beats per minute (bpm) and an increase of ≥10 bpm from baseline. Change From Baseline to Week 4 and Week 8 in Weight [ Time Frame: Baseline to Weeks 4 and 8 ] Change in weight = Post-baseline visit minus baseline. Eligibility Criteria Go (...) Disorder (OCD)) or Major Depressive Disorder, in the investigator's judgment. Any previous diagnosis of a bipolar disorder, schizophrenia or OCD. Depression with catatonic features (according to DSM-IV), depression with post-partum onset, or organic mental disorders. The presence of an Axis II disorder Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information

2007 Clinical Trials

1277. Wound Closure Techniques

to skin closure with either Dermabond or suture. Surgeon preference will dictate usage of 4-0 monocryl or 4-0 vicryl for skin closure for patients randomized to the suture arm. The circulating nurse will time all skin closures. The surgeon will complete a 3 question survey immediately postop. At the 6 week post partum visit, patients and the health care professional will complete a brief query regarding cosmetic appeal and pain. A disposable camera will be supplied to each provider office and a photo (...) sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00282633 Recruitment Status : Unknown Verified October 2007 by Hartford Hospital. Recruitment status was: Recruiting First Posted : January 27, 2006 Last Update Posted : October 31, 2007 Sponsor: Hartford Hospital Information provided by: Hartford Hospital Study Details Study Description Go to Brief Summary: A Comparison of Skin Closure

2006 Clinical Trials

1278. An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression

completing Segment B may be eligible for enrollment into Segment C, a 44-week, double blind extension. All randomized patients must complete a post-study visit 1 week after intake of the last dose of study medication. Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Actual Enrollment : 467 participants Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double (Participant, Investigator) Primary Purpose: Treatment Official Title (...) pattern or post-partum onset. 2. The duration of the current depressive episode is greater than 2 years. 3. Patients who are currently suicidal or have a history of a suicide attempt within 3 years prior to entry. 4. Patients whose current depressive episode is secondary to a general medical disorder. 5. Patients with a history or presence of bipolar disorders or psychotic disorders according to the D and L criteria of the MINI. 6. Patients with alcohol dependence or abuse or substance dependence

2005 Clinical Trials

1279. Management of Superficial Thrombophlebitis

superficial thrombophlebitis by ultrasound imaging Exclusion Criteria: Active, clinically significant bleeding Known hypersensitivity to NSAIDS, heparin or derivatives Currently pregnant or < 1 week post-partum Acquired bleeding diathesis Known inherited bleeding disorder Renal failure Extremes of weight unable to return for repeat diagnostic testing or follow-up visit Concurrent deep-vein thrombosis Contacts and Locations Go to Information from the National Library of Medicine To learn more about (...) of Oklahoma Pfizer Investigators Layout table for investigator information Principal Investigator: Suman Rathbun, M.D. University of Oklahoma Medicine/Cardiovascular Section More Information Go to Publications of Results: Layout table for additonal information Responsible Party: University of Oklahoma ClinicalTrials.gov Identifier: Other Study ID Numbers: 10341 ORA-20030415 ( Other Identifier: University of Oklahoma Office of Research Administration ) First Posted: December 12, 2005 Results First Posted

2005 Clinical Trials

1280. Treatment of Upper Extremity Deep-Vein Thrombosis

Ages Eligible for Study: 18 Years and older (Adult, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: Patients with confirmed upper extremity DVT diagnosed by ultrasound imaging or venogram Exclusion Criteria: Active, clinically significant bleeding Known hypersensitivity to heparin or low-molecular weight heparin Currently pregnant or less than 1 week post-partum Acquired bleeding diathesis Known inherited bleeding disorder Renal failure (...) Rathbun, Professor of Medicine, University of Oklahoma ClinicalTrials.gov Identifier: Other Study ID Numbers: 10206 ORA-20020622 ( Other Identifier: University of Oklahoma Office of Research Administration ) First Posted: October 28, 2005 Results First Posted: February 4, 2013 Last Update Posted: February 21, 2013 Last Verified: February 2013 Keywords provided by Suman Rathbun, University of Oklahoma: Upper Extremity Deep-Vein Thrombosis DVT Fragmin Deep-Vein Thrombosis Thrombosis Additional relevant

2005 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>